SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-065567
Filing Date
2023-05-30
Accepted
2023-05-26 17:39:13
Documents
5
Effectiveness Date
2023-05-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2317005d1_s8.htm S-8 49909
2 EXHIBIT 5.1 tm2317005d1_ex5-1.htm EX-5.1 9672
3 EXHIBIT 23.1 tm2317005d1_ex23-1.htm EX-23.1 2363
4 EX-FILING FEES tm2317005d1_ex-filingfees.htm EX-FILING FEES 18381
5 GRAPHIC tm2317005d1_ex5-1img001.jpg GRAPHIC 3162
  Complete submission text file 0001104659-23-065567.txt   85855
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272255 | Film No.: 23970505
SIC: 2834 Pharmaceutical Preparations